[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

GeoVax Labs Inc (GOVX) - Strategic SWOT Analysis Review

August 2019 | 38 pages | ID: GD445D27310EN
GlobalData

US$ 125.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
GeoVax Labs Inc (GOVX) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

GeoVax Labs Inc (GeoVax) is a clinical-stage biotech company that develops human vaccines for human immunodeficiency virus (HIV), cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company’s vaccine development programs focus on HIV, Zika virus and hemorrhagic fever viruses (Ebola, Marburg, Lassa fever) and for cancer immunotherapy. Its advanced vaccines under development act against the clade B and clade C subtype of the HIV virus. GeoVax developed its proprietary vaccine technology in collaboration with the U.S. National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Emory University. GeoVax is headquartered in Smyrna, Georgia, the US.

GeoVax Labs Inc Key Recent Developments

May 22,2019: GeoVax to conduct partnering meetings during BIO International Convention
May 15,2019: GeoVax to present unique technology at New York Academy of Sciences Vaccine Conference
May 14,2019: GeoVax reports 2019 first quarter financial results and highlights Corporate Development Progress
May 14,2019: GeoVax Labs announces 2019 first quarter financial results
Mar 27,2019: GeoVax reports 2018 year-end financial results

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

GeoVax Labs Inc - Key Facts
GeoVax Labs Inc - Key Employees
GeoVax Labs Inc - Key Employee Biographies
GeoVax Labs Inc - Major Products and Services
GeoVax Labs Inc - History
GeoVax Labs Inc - Company Statement
GeoVax Labs Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
GeoVax Labs Inc - Business Description
GeoVax Labs Inc - Corporate Strategy
GeoVax Labs Inc - SWOT Analysis
SWOT Analysis - Overview
GeoVax Labs Inc - Strengths
GeoVax Labs Inc - Weaknesses
GeoVax Labs Inc - Opportunities
GeoVax Labs Inc - Threats
GeoVax Labs Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
GeoVax Labs Inc, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

May 22, 2019: GeoVax to conduct partnering meetings during BIO International Convention
May 15, 2019: GeoVax to present unique technology at New York Academy of Sciences Vaccine Conference
May 14, 2019: GeoVax reports 2019 first quarter financial results and highlights Corporate Development Progress
May 14, 2019: GeoVax Labs announces 2019 first quarter financial results
Mar 27, 2019: GeoVax reports 2018 year-end financial results
Mar 11, 2019: GeoVax provides product development and corporate update
Jan 22, 2019: GeoVax to Present at the 2019 ASM Biothreats Conference
Sep 12, 2018: Geovax to report vaccine development progress at the 12th vaccine congress in Budapest
Aug 29, 2018: GeoVax Strengthens Scientific Staff and Expertise
Aug 14, 2018: GeoVax names David Dodd as Chairman, President and Chief Executive Officer

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

GeoVax Labs Inc, Key Facts
GeoVax Labs Inc, Key Employees
GeoVax Labs Inc, Key Employee Biographies
GeoVax Labs Inc, Major Products and Services
GeoVax Labs Inc, History
GeoVax Labs Inc, Subsidiaries
GeoVax Labs Inc, Key Competitors
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
GeoVax Labs Inc, Recent Deals Summary

LIST OF FIGURES

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

COMPANIES MENTIONED

Johnson & Johnson
Novavax Inc
Sanofi
Inovio Pharmaceuticals Inc
Merck & Co Inc
Profectus BioSciences Inc
NewLink Genetics Corp
GlaxoSmithKline AG
Protein Sciences Corp


More Publications